Both Lorazepam and Sucralfate offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Sucralfate is gentler on the liver and kidneys and has a better safety profile for long-term use, particularly for older patients or those with pre-existing conditions.

Lorazepam has a lower risk of dependency, making it a safer option for patients concerned about addiction.

Sucralfate offers greater flexibility with different delivery forms, making it suitable for patients with specific preferences or medical needs.

Sucralfate is better for patients with cardiovascular or diabetes-related issues, as it has fewer interactions with other medications.

Sucralfate is better suited for chronic conditions, offering longer-lasting effects and a favorable safety profile for long-term use. Its flexibility in administration makes it a strong option for various patient needs.